Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
FDA-approved GLP-1 receptor agonists include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin), exenatide (Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
Some pharma companies are setting up direct-to-consumer websites where a patient, for example, Lily has one where they can go in and get ZepBound, which is one of their GLP-1 weight loss drugs
Telehealth consultations allow for evaluation of medical history, current health conditions, and weight-related concerns before determining whether GLP-1 tirzepatide may be appropriate
Availability of certain formats varies by state and is subject to provider approval
PLoS ONE, 5 (1), e8976
Heise T, Mari A, DeVries JH, et al
US$ 28.10
US$ 27.98
US$ 27.99
US$ 23.61
US$ 23.02
US$ 29.84
US$ 26.46
US$ 21.48
US$ 28.00
